Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which molecular pathology, cellular stress and network dysfunction accumulate over many years before dementia becomes clinically ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

UNIC Athens has launched its new Evolve Lecture Series with an inaugural lecture by David Sinclair, Professor of Genetics at Harvard Medical School and one of the world’s foremost researchers on ...

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

Brain metastases are a major challenge in HER2-positive metastatic breast cancer; epidemiologic series suggest that roughly 30%–50% of patients eventually develop brain involvement, which is ...